I just finished my second infusion of Arzerra, So far, I have had the same experience with this drug and application as with Rituximab, which I tolerated well. I have had none of the side effects that were listed in the Arzerra information. I have six more weeks of infusions before I will get some follow up testing to see if it is effective.
Shared reviews and ratings
Most Helpful
Most Recent
Highest Total Rating
High Satisfaction
Low Satisfaction
No data
Kascll | 55-64 | Male | On medication for 1 to 6 months | Patient
2/21/2015
Condition: Chronic Lymphocytic Leukemia
Overall rating 2.3
Effectiveness
Ease of Use
Satisfaction
I have experienced 5 of 6 main SAEs on this medication which I am taking with Zydelig in a clinical trial. I had very bad diarrhea after the second infusion, and after completing the weekly rounds have found that I am having a bad diarrhea, vomiting,chills, fever situation for the past four months shortly after the infusion reaction, I have spent countless hours I'll while on this product and am in the hospital for several days again as I write due to more medication interaction.
1
Report this post
tpard | 45-54 | Male | On medication for less than 1 month | Patient
I just finished my second infusion of Arzerra, So far, I have had the same experience with this drug and application as with Rituximab, which I tolerated well. I have had none of the side effects that were listed in the Arzerra information. I have six more weeks of infusions before I will get some follow up testing to see if it is effective.
IMPORTANT INFORMATION ABOUT USER-GENERATED CONTENT ON WEBMD
The opinions expressed in WebMD User-generated content areas like communities, reviews, ratings, or blogs are solely those of the User, who may or may not have medical or scientific training. These opinions do not represent the opinions of WebMD. User-generated content areas are not reviewed by a WebMD physician or any member of the WebMD editorial staff for accuracy, balance, objectivity, or any other reason except for compliance with our Terms and Conditions.